BSE Live
Mar 09, 14:40Prev. Close
61.16
Open Price
61.16
Bid Price (Qty.)
58.52 (10)
Offer Price (Qty.)
59.04 (103)
NSE Live
Mar 09, 14:38Prev. Close
61.00
Open Price
61.00
Bid Price (Qty.)
58.66 (43)
Offer Price (Qty.)
58.73 (61)
| Profit & Loss account of Brooks Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 85.21 | 85.27 | 80.11 | 56.08 | 52.54 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 85.21 | 85.27 | 80.11 | 56.08 | 52.54 | |
| Total Operating Revenues | 85.21 | 85.27 | 80.11 | 56.08 | 52.54 | |
| Other Income | 2.36 | 0.01 | 0.01 | 0.92 | 0.13 | |
| Total Revenue | 87.58 | 85.27 | 80.12 | 57.00 | 52.67 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 60.41 | 59.74 | 56.78 | 36.03 | 37.46 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 4.48 | 4.23 | 2.29 | 2.01 | 2.15 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.24 | -1.19 | 0.57 | 0.28 | -0.42 | |
| Employee Benefit Expenses | 4.73 | 2.56 | 1.74 | 2.73 | 2.39 | |
| Finance Costs | 0.44 | 0.12 | 0.11 | 1.72 | 1.49 | |
| Depreciation And Amortisation Expenses | 1.10 | 0.83 | 0.81 | 0.66 | 0.61 | |
| Other Expenses | 8.60 | 11.41 | 8.23 | 4.40 | 1.68 | |
| Total Expenses | 80.01 | 77.70 | 70.54 | 47.83 | 45.37 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 7.57 | 7.57 | 9.58 | 9.17 | 7.30 | |
| Exceptional Items | 2.78 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 10.35 | 7.57 | 9.58 | 9.17 | 7.30 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.93 | 1.51 | 2.27 | 1.83 | 1.45 | |
| Less: MAT Credit Entitlement | 0.81 | 1.40 | 0.00 | 1.70 | 1.31 | |
| Deferred Tax | -0.24 | 0.22 | 0.17 | 0.20 | 0.16 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.88 | 0.33 | 2.44 | 0.33 | 0.30 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 9.47 | 7.24 | 7.14 | 8.84 | 6.99 | |
| Profit/Loss From Continuing Operations | 9.47 | 7.24 | 7.14 | 8.84 | 6.89 | |
| Profit/Loss For The Period | 9.47 | 7.24 | 7.14 | 8.84 | 6.89 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 5.85 | 4.47 | 4.41 | 6.55 | 6.97 | |
| Diluted EPS (Rs.) | 5.85 | 4.47 | 4.41 | 6.55 | 7.00 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 11.54 | 13.56 | 11.55 | 7.25 | 6.32 | |
| Indigenous Raw Materials | 48.87 | 30.71 | 45.64 | 32.71 | 30.98 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 10.00 |
18.02.2026
Brooks Labs Consolidated December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
18.02.2026
Brooks Labs Consolidated December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y